EFDID: 322312EFD: View Filing

Issuer: Kalytera Therapeutics, Inc. (0001639643) - D

Accession: 0001639643-19-000004 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
  • Entity Name:
    Kalytera Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    BRITISH COLUMBIA, CANADA
  • Year of Inc:
    Within 5 years (2016)
  • Address:
    4040 CIVIC CENTER DRIVE, SUITE 200
    SAN RAFAEL, CA 94903
  • Persons:
    Related Persons 5
    Robert Farrell
    Executive Officer, Director
    Ronald Erickson
    Director
    Robin Hutchison
    Director
    Jeff Paley
    Director
    Victoria Rudman
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    09/24/2019
  • First Sale Date:
    09/13/2019
  • Offering Amount:
    $2,407,562
  • Amount Sold:
    $760,000
  • Amount Remaining:
    $1,647,562
  • Exemptions:
    Rule 506(c)
  • Security Type(s):
    Equity
  • Sales Clarification:
    Estimated amounts are based on CAD$1.3153/USD$1.00 exchange rate on 2019-09-10, when the offering price was set. Total Offering Amount includes aggregate exercise price of USD$1,267,138 in respect of unexercised warrants issued as part of the offering.
EFD: Current State Notices

Notices found in EFD

Filed:CA, KY, NJ
Inactive:GA, WA
EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Alere Financial Partners, a division of Cova Capital Partners LLC 109761 None None CA, GA, KY, MA, NJ, NY, WA
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Kalytera Therapeutics, Inc./s/ Robert FarrellRobert FarrellPresident, CEO and Director2019-09-24